FormWeb • Do Not Crush

Franciscan Missionaries of Our Lady Health System

Questions or Suggestions Drug Information Questions

Webpage Links

Add Formweb to your mobile device

Android iOS

*COVID-19 Pharmacy Resources

Franciscan Missionaries of Our Lady Health System

Questions or Suggestions Drug Information Questions

Do Not Crush

Please review each of these drugs carefully.

acetaminophen	Controlled-release Tablet
albuterol	Extended-release Tablet
alendronate	Tablet - Note: Mucous membrane irritant
ALPRAZolam	Extended-release Tablet
amoxicillin	Extended-release Tablet
amoxicillin-clavulanate	Extended-release (b,h) Tablet
amphetamine-dextroamphetamine	Extended-release Capsule (a)
aspirin	Delayed-release Tablet Enteric-coated Tablet
aspirin-dipyridamole	Extended-release Capsule
atomoxetine	Capsule - Note: capsule contents can cause ocular irritation
benzonatate	Capsule - Note: swallow whole; local anesthesia of the oral mucosa; choking could occur
bisacodyl	Enteric-coated (c) Tablet Capsule - Liquid filled
brompheniramine-phenylephrine (non-formulary)	Extended-release (b) Capsule
budesonide	Extended-release Capsule Enteric-coated (a) Capsule Tablet - Note: coating on tablet is designed to break down at pH of 7.0 or above
buPROPion	Extended-release Tablet Slow-release Tablet
carBAMazepine	Extended-release (a) Capsule Extended-release (b) Tablet
carbidopa-levodopa	Extended-release (h) Tablet
carvedilol	Extended-release (a) Capsule - Note: may add contents of capsule to chilled, not warm, applesauce and consume immediately
cefaclor	Extended-release Tablet
cefuroxime	Tablet - Note: Taste (b) / use suspension for children
charcoal	Enteric-coated Tablet
chlorpheniramine	Extended-release (b) Tablet
cinacalcet	Tablet - Note: tablets are not scored and cutting may cause variable dosage accuracy
ciprofloxacin	Extended-release (b) Tablet Extended-release Tablet
clarithromycin	Extended-release Tablet
cloNIDine	Extended-release Tablet
colestipol	Slow-release Tablet
cyclobenzaprine	Extended-release Capsule
cyclophosphamide	Tablet - Note: drug may be crushed but company recommends using injection
dabigatran	Capsule - Note: bioavailability increases by 75% when the pellets are taken without the capsule shell
darifenacin (non-formulary)	Slow-release Tablet
desvenlafaxine	Extended-release Tablet
dexmethylphenidate	Extended-release (a) Capsule
dextromethorphan-guaifenesin	Extended-release (h) Tablet Extended-release Tablet Slow-release Tablet
dextromethorphan/guaifenesin/phenylephrine	Slow-release (h) Tablet
diclofenac	Enteric-coated Tablet Extended-release Tablet Delayed-release Tablet
dilTIAZem	Tablet - Note: although not in the PI, the drug has a coating that is intended to release the drug over approximately 3 hours Extended-release (a) Capsule Extended-release Tablet
disopyramide	Extended-release Capsule Note: within a special capsule
divalproex sodium	Slow-release (b) Capsule - Note: mucous membrane irritant Delayed-release Tablet Extended-release Tablet Extended-release (a) Capsule
docusate	Capsule - Note: Taste (e)
donepezil	Tablet - Note: crushing the 23 mg tablet may significantly increase the rate of absorption; the 5 and 10 mg tablet are not affected
doxazosin	Extended-release Tablet
doxycycline	Delayed-release Capsule
DULoxetine	Extended-release (a) Capsule - Note: may add contents of capsule to apple juice or applesauce but NOT chocolate
dutasteride (non-formulary)	Capsule - Note: drug may cause fetal abnormalities; women who are, or may become, pregnant, should not handle capsules; all women should use caution in handling capsules, especially leaking capsules
ergocalciferol	Liquid filled (d) Capsule
erythromycin	Enteric-coated (b) Tablet Enteric-coated Tablet Delayed-release Tablet Enteric-coated Pellets (a) Capsule
esomeprazole	Delayed-release (a) Capsule
etravirine	Tablet - Note: tablet should be swallowed whole and not crushed; tablet may be dispersed in water
fenofibric acid	Extended-release Capsule
fentaNYL	Slow-release Lozenge - Note: this lollipop delivery system requires the patient to slowly dissolve in mouth
ferrous gluconate	Enteric-coated Tablet
ferrous sulfate	Enteric-coated (b) Tablet Slow-release Tablet
fesoterodine (non-formulary)	Extended-release Tablet
fexofenadine-pseudoephedrine (non-formulary)	Extended-release Tablet
finasteride	Tablet - Note: women who are, or may become, pregnant, should not handle crushed or broken tablets
FLUoxetine	Enteric-Coated Tablet
fluvoxaMINE	Extended-release Capsule
gabapentin	Extended-release Tablet
galantamine	Extended-release Capsule
ganciclovir	Capsule - Note: Skin irritant
glipiZIDE	Extended-release Tablet
guaiFENesin	Extended-release (h) Tablet Slow-release Tablet
guaifenesin-pseudoephedrine	Extended-release Capsule Extended-release Tablet
guanFACINE	Extended-release Tablet
HYDROmorphone	Extended-release Tablet - Note: breaking, chewing, crushing, dissolving before swallowing or injecting could result in overdose
hydroxyurea	Capsule - Note: exposure to the powder may cause serious skin toxicities; healthcare workers should wear gloves to administer
hyoscyamine	Extended-release (h) Tablet Extended-release Capsule Controlled-release Tablet
ibandronate	Tablet - Note: chewed, crushed, or sucked tablets may cause oropharyngeal irritation
ibuprofen	Tablet - Note: taste (e)
imatinib	Tablet - Note: Taste (h) may be dissolved in water or apple juice
indomethacin	Extended-release (a,b) Capsule
isosorbide dinitrate	Sublingual form (g) Tablet
isosorbide mononitrate	Extended-release (h) Tablet
isradipine	Extended-release Tablet
lamoTRIgine	Extended-release Tablet
lansoprazole	Delayed-Release Capsule Tablet - Note: orally disintegrating do not swallow; dissolve in water only and dispense via dosing syringe or NG tube Slow-release Suspension - Note: contains enteric-coated granules; mix with water only; not for NG use
levETIRAcetam	Extended-release (b) Tablet
lithium	Extended-release Tablet
lopinavir-ritonavir	Film-coated (b) Tablet - Note: active ingredients are surrounded by a wax matrix to prevent healthcare exposure; women who are, or may become, pregnant, should not handle crushed or broken tablets
loratadine	Extended-release Tablet
loratadine-pseudoephedrine	Extended-release (b) Tablet Extended-release Tablet
memantine	Extended-release (a) Capsule
mesalamine	Extended-release (a) Capsule - Note: maintain pH at less than or equal to 6.0 Slow-release (a) Tablet Delayed-release Tablet
metFORMIN	Extended-release Tablet
methylphenidate	Extended-release Tablet Extended-release (a) Capsule
metoprolol	Extended-release (h) Tablet
metroNIDAZOLE	Extended-release Tablet
minocycline	Extended-release Tablet
mirabegron (non-formulary)	Extended-release Tablet
morphine	Enteric-coated (a; not pudding) Capsule Extended-release (a) Capsule - Note: may add contents of capsule to apple juice or applesauce but NOT chocolate Extended-release (a) Capsule - Note: do not give via N/G tube Extended-release (b) Tablet
mycophenolate mofetil	Capsule, Tablet - Note: Teratogenic potential (i) Delayed-release Tablet
mycophenolic acid	Delayed-Release Tablet
naproxen	Delayed-release Tablet Enteric-coated Tablet Extended-release Tablet
nevirapine	Extended-release (b) Tablet
niacin	Slow-release (h) Capsule; Tablet
niCARdipine	Extended-release Capsule
nicotine	Lozenge - Note: integrity compromised by chewing or crushing
NIFEdipine	Extended-release Tablet
nitroglycerin	Sublingual route (g) Tablet
omega-3 polyunsaturated fatty acids	Capsule - Note: contents of capsule may erode walls of styrofoam or plastic materials
omeprazole	Delayed-release (a) Capsule Delayed-Release Tablet
orphenadrine	Extended-release Tablet
oxybutynin	Extended-release Tablet
oxyCODONE	Extended-release Tablet - Note: tablet disruption may cause a potentially fatal overdose of oxyCODONE
oxyMORphone (non-formulary)	Extended-release Tablet
paliperidone	Extended-release Tablet
pancrelipase	Enteric-coated (a) Capsule Extended-release (a) Capsule Delayed-release (a) Capsule
pantoprazole	Slow-Release Tablet
PARoxetine	Extended-release Tablet
pentoxifylline	Extended-release Tablet
piroxicam	Capsule - Note: Mucous membrane irritant
posaconazole	Delayed-release Tablet - Note: company literature not available to show implications
potassium bicarbonate	Effervescent (f) Tablet
potassium chloride	Extended-release (b) Tablet Extended-release (b,h) Tablet - Note: to make a liquid, place tablet in 120 mL of water; disperse for 2 minutes; stir Extended-release (a,b) Capsule
potassium citrate	Wax-coated Tablet - prevents upper GI release
pramipexole	Extended-release Tablet
predniSONE	Delayed-Release Tablet - Note: release is dependent upon intact coating
propafenone	Extended-release Capsule
propranolol	Extended-release Capsule
pseudoephedrine	Extended-release (b) Tablet
pyridostigmine	Extended-release (b) Tablet
QUEtiapine	Extended-release Tablet
raloxifene	Tablet - Note: Taste; teratogenic potential (i)
ranolazine	Slow-Release Tablet
risedronate	Extended-release Tablet - Note: tablet coating is an important part of the delayed release
ritonavir	Tablet - Note: crushing tablets has resulted in decreased bioavailability of drug (b)
rivaroxaban	Tablet - Note: Crushed tablet must be given within 4 hours
rOPINIRole	Extended-release Tablet
sevelamer	Tablet - Note: tablets expand in liquid if broken or crushed (b)
sirolimus	Tablet - Note: pharmacokinetic NanoCrystal technology may be affected (b)
sulfaSALAzine	Delayed-release Tablet
tamsulosin	Slow-release Capsule
tapentadol (non-formulary)	Extended-release Tablet - Note: toxic dose may occur if tablet is split or crushed, causing rapid release and absorption of a potentially fatal dose
temozolomide	Capsule - Note: accidentally opened or damaged capsules require rigorous precautions to avoid inhalation or contact with the skin or mucous membranes (i)
theophylline	Extended-release Capsule - Note: contains beads that dissolve throughout the GI tract Extended-release Tablet Slow-release Tablet
tipranavir	Capsule - Note: oil emulsion within spheres; taste
tolterodine (non-formulary)	Extended-release Capsule
topiramate	Tablet/Capsule - Note: Taste (a)
traMADol	Extended-release Tablet - Note: tablet disruption may cause a potentially fatal overdose of drug
traZODone	Extended-release Tablet
valGANciclovir	Tablet - Note: Teratogenic and irritant potential (i,b)
valproic acid	Slow-Release Capsule
venlafaxine	Extended-release Capsule
verapamil	Extended-release (h) Tablet Sustained-release (a) Capsule Extended-release (a) Capsule
zolpidem	Extended-release Tablet Sublingual form (g) Tablet

Pharmacy Phone Numbers

Our Lady of the Lake Regional Medical Center
225-765-4434
Our Lady of the Lake Children’s Hospital
225-374-1380
Our Lady of the Lake Ascension Hospital
225-647-5057
Our Lady of the Lake Assumption Community Hospital
985-369-4290
Our Lady of Angels Hospital
985-730-6789

Our Lady of Lourdes Hospital
337-470-2866
Our Lady of Lourdes Women and Children’s
337-470-5070
Our Lady of Lourdes Heart Hospital
337-470-1080
St. Dominic Jackson Memorial Hospital
601-200-6000
St. Francis Medical Center
318-966-3461